ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the tr…
Biotechnology
US, San Diego [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about ACADIA Pharmaceuticals Inc.'s gradings, price targets and earnings estimates. None
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2014 | -0.4400 | -0.665 | 1 | 0.10 | -37 | -76 | -38 | -76 | -38 | -76 | 12 | 0.08 |
| 2015 | -0.9500 | -1.583 | 0.12 | 0.97 | -92 | -132 | -93 | -131 | -93 | -132 | 32 | 0.76 |
| 2016 | -1.6300 | -2.342 | 0.06 | 14 | -164 | -241 | -164 | -238 | -164 | -242 | 90 | 11 |
| 2017 | -2.3400 | -2.397 | 17 | 126 | -271 | -319 | -272 | -316 | -272 | -322 | 186 | 99 |
| 2018 | -2.3600 | -1.991 | 124 | 223 | -289 | -262 | -292 | -257 | -292 | -264 | 255 | 175 |
| 2019 | -1.9400 | -1.618 | 223 | 337 | -245 | -246 | -247 | -239 | -247 | -259 | 265 | 265 |
| 2020 | -1.6000 | -1.840 | 339 | 443 | -235 | -257 | -246 | -247 | -246 | -262 | 325 | 385 |
| 2021 | -1.7900 | -1.019 | 441 | 487 | -281 | -187 | -286 | -182 | -286 | -190 | 388 | 455 |
| 2022 | -1.0500 | -1.315 | 484 | 514 | -167 | -252 | -170 | -246 | -170 | -254 | 396 | 466 |
| 2023 | -1.3400 | -0.358 | 517 | 719 | -215 | -61 | -223 | -271 | -223 | -280 | 369 | 512 |
| 2024 | - | 0.541 | - | 952 | - | 88 | - | -429 | - | -435 | - | 747 |
| 2025 | - | 0.821 | - | 1,055 | - | 150 | - | -475 | - | -482 | - | 828 |
| 2026 | - | 2.F12X/td> | - | 2.F12X/td> | - | 2.F12X/td> | - | 2.F121/td> | - | 2.F121 | - | 2.F121 |
| 2027 | - | 1.F13X/td> | - | 1.F13X/td> | - | 1.F13X/td> | - | 1.F131/td> | - | 1.F131 | - | 1.F131 |
| 2028 | - | 0.F14X/td> | - | 0.F14X/td> | - | 0.F14X/td> | - | 0.F141/td> | - | 0.F141 | - | 0.F141 |